Fig. 3From: The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology studyA PPI networks. B A heatmap of binding energy on 20 SMs against VEGFA. C The conformer of myricetin-VEGFA. D The conformer of quercetin-VEGFA. E Bubble plot of 3 signaling pathways associated with occurrence and development of NAFLDBack to article page